Anagram Partners and CMS Induslaw have guided Hindustan Unilever on its acquisition of 49 percent stake in OZiva, operating through Zywie Ventures for a consideration amount of INR 824 crore. First Principles Law represented the exiting investors including Eight Roads Ventures India III and F-Prime Capital Partners, Life Sciences Fund VI while Kaizen Law represented the promoters including Aarti Gill and Mihir Gadani on this transaction.
Hindustan Unilever had previously acquired a 51 percent stake in Zywie for INR 264.28 crore in 2023. The latest transaction values Zywie at nearly INR 1,682 crore.
The transaction was executed under a pre‑agreed valuation framework approved by Hindustan Unilever’s board for the balance stake purchase after the three‑year lock‑in period.
Zywie is a leading plant-based nutrition and wellness brand, offering clean, science-backed products across categories such as women’s health, skin, hair, and general wellbeing.
Anagram’s team was led by partner Harman Walia and comprised Sanjana Mathur, Tanmaya Negi, Aman Gupta, and Aditi Sinha.
The CMS INDUSLAW Corporate and IP teams advised HUL on all aspects of the transactions with strategic inputs from founding and senior partner Avimukt Dar. The team was guided by principal associate Shivani Singh and associates Rusha Ghosh Dastidar and Prakhar Srivastava on corporate matters. Partner Bharadwaj Jaishankar, senior associate Trushita Mehra and associate Ishita Goyal acted on IP related matters.
